It is a pharma private limited company based in Kalyan, Maharashtra, India, established in 2012.
2012 | Kalyan, Maharashtra, India | ActiveMedmark Pharmaceuticals Private Limited, a active private limited company, was established on 04 June 2012 in Kalyan, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U33119MH2012PTC231810. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Gyanesh Shivnarayan Singh (Director), Anita Gyanesh Singh (Director). It holds ₹0.90 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No.06,Bappa Maurya Building,, Madhala Pada, Kalyan, Maharashtra, 421201.
U33119MH2012PTC231810
231810
04 June 2012
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Medmark Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gyanesh Shivnarayan Singh | Director | 04 Jun 2012 | Current |
| Anita Gyanesh Singh | Director | 04 Jun 2012 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Medmark Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 77.61% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
|
In 2022, Medmark Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹898,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Jul 2020 | Idbi Bank Limited | ₹0.10 M | Open |
| 29 Jul 2015 | Idbi Bank Limited | ₹0.80 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Medmark Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Medmark Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medmark Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Medmark Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Medmark Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity A charge with Idbi Bank Limited amounted to Rs. 0.10 M with Charge ID 100348045 was registered on 06 Jul 2020. was completed.
A charge with Idbi Bank Limited amounted to Rs. 0.80 M with Charge ID 10600046 was registered on 29 Jul 2015. was recorded as a recent event.
Progress on Gyanesh Shivnarayan Singh was appointed as a Director was appointed as a Director on 04 Jun 2012 & has been associated with this company since 13 years 6 months . was documented.
Progress on Anita Gyanesh Singh was appointed as a Director was appointed as a Director on 04 Jun 2012 & has been associated with this company since 13 years 6 months . was documented.
The CIN of Medmark Pharmaceuticals Private Limited is U33119MH2012PTC231810.
Medmark Pharmaceuticals Private Limited is headquartered at Shop No.06,Bappa Maurya Building,, Madhala Pada, Kalyan, Maharashtra, 421201.
Medmark Pharmaceuticals Private Limited was incorporated on 04 June 2012.
The current directors of Medmark Pharmaceuticals Private Limited are
The primary industry of Medmark Pharmaceuticals Private Limited is Trade.
Medmark Pharmaceuticals Private Limited is unlisted.
The authorized capital of Medmark Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Medmark Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX